Navigation Links
Glenn Foundation for Medical Research commits $5 million to study aging
Date:7/10/2008

er life brings with it vulnerability to diseases such as Alzheimer's, Parkinson's, osteoporosis, diabetes and others. Funding of aging research is an important path to the alleviation of suffering and reduced healthcare costs. This research forms the backbone of scientific advances in our understanding of aging. AFAR is a key organization in assuring that the best research remains supported."

Nearly 2,500 researchers have been recipients of AFAR-supported grant awards, many of whom have gone on to distinguish themselves as leaders in the field of aging research, chairing departments and running laboratories at major academic institutions. Many of the nation's leaders in biogerontology have been beneficiaries of AFAR grant programs.


'/>"/>

Contact: Stacey Harris
stacey@afar.org
212-703-9977
American Federation for Aging Research
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Balzan Foundation announces 2007 winners
2. Keck Foundation funds study of biological interactions with nanomaterials
3. Yu receives research funding from the Wallace H. Coulter Foundation
4. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
5. Simons Foundation awards Emory scientists $3M for autism gene research
6. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
7. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
8. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
9. CONRAD receives $28.5M Gates Foundation grant for HIV prevention research
10. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
11. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10Brooding fishes take up nutrients from their own children 2First-in-class treatment for acute leukemia 2First-in-class treatment for acute leukemia 3Michael J Fox Foundation Commits Up to 245 Million to Help Advance Neurotrophic Factors From Promise to Reality As Parkinsons Treatment 58205 1Michael J Fox Foundation Commits Up to 245 Million to Help Advance Neurotrophic Factors From Promise to Reality As Parkinsons Treatment 58205 2American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 1American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 2American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 3American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 4American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 5American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 6Abbotts XIENCE V 28R 29 Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS 28R 29 Liberte in Investigator Initiated 5042 1Abbotts XIENCE V 28R 29 Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS 28R 29 Liberte in Investigator Initiated 5042 2Abbotts XIENCE V 28R 29 Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS 28R 29 Liberte in Investigator Initiated 5042 3